<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The diagnosis of histiocytic/dendritic cell (H/DC) <z:hpo ids='HP_0100242'>sarcomas</z:hpo> is currently based on <z:mp ids='MP_0000002'>morphology</z:mp> and the presence of immunophenotypic features of H/DC differentiation </plain></SENT>
<SENT sid="1" pm="."><plain>The issue whether clonal immunoglobulin receptor gene rearrangements are present in H/DC <z:hpo ids='HP_0100242'>sarcomas</z:hpo> has been debated over decades until the recent data by Feldman et al, which provided compelling evidence that patients with follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and concurrent/synchronous H/DC <z:hpo ids='HP_0100242'>sarcoma</z:hpo> share identical genotypic features, suggested the possibility of <z:mpath ids='MPATH_85'>transdifferentiation</z:mpath> or <z:e sem="disease" ids="C0002793" disease_type="Neoplastic Process" abbrv="">dedifferentiation</z:e> of 2 otherwise morphologically and immunophenotypically distinctive <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Here we investigated the molecular characteristics of 23 patients with <z:hpo ids='HP_0003745'>sporadic</z:hpo> H/DC <z:hpo ids='HP_0100242'>sarcoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Nine of the 23 cases (39%) showed clonal IGH (+/-IGK) gene rearrangements, whereas 2 (9%) cases showed only clonal IGK gene rearrangements, which were further validated and confirmed by direct DNA sequencing </plain></SENT>
<SENT sid="4" pm="."><plain>One histiocytic <z:hpo ids='HP_0100242'>sarcoma</z:hpo> showed t(14;18) by quantitative-polymerase chain reaction, which was confirmed by fluorescence in situ hybridization analysis showing IGH/BCL2 fusions in neoplastic histiocytes </plain></SENT>
<SENT sid="5" pm="."><plain>Notably, <z:hpo ids='HP_0000001'>all</z:hpo> IGH/IGK-positive H/DC <z:hpo ids='HP_0100242'>sarcomas</z:hpo> were negative for B-cell-associated transcription factors PAX5 and BOB.1, whereas 4 of 7 IGH/IGK-positive histiocytic <z:hpo ids='HP_0100242'>sarcoma</z:hpo> cases were positive for Oct2 </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, no evidence of <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">Epstein-Barr virus infection</z:e> was detected in 8 of 11 IGH/IGK-positive H/DC <z:hpo ids='HP_0100242'>sarcoma</z:hpo> cases by in situ hybridization, suggesting that <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">Epstein-Barr virus infection</z:e> may not play an important role in the pathogenesis of these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>This study provides evidence that clonal immunoglobulin receptor gene rearrangements may be detected at a high frequency in <z:hpo ids='HP_0003745'>sporadic</z:hpo> H/DC <z:hpo ids='HP_0100242'>sarcomas</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>The findings suggest that a large subset of H/DC <z:hpo ids='HP_0100242'>sarcomas</z:hpo> have inherited B-cell genotypes, thus providing new insights for the pathogenesis of these rare but aggressive <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
</text></document>